Home › Compare › JNPKF vs ABBV
JNPKF yields 1.37% · ABBV yields 3.06%● Live data
📍 JNPKF pulled ahead of the other in Year 5
Combined, JNPKF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JNPKF + ABBV for your $10,000?
Jenoptik AG provides advanced photonic solutions and smart mobility solutions in Germany and internationally. The company provides imaging solutions and cameras, including microscope and thermographic camera, imaging modules, polymer-based camera modules, and miniaturized digital microscope subsystem; and laser and laser technology, such as laser ablation, scoring, cutting, and rangefinder, as well as laser OEM solutions comprising diode laser and disk laser technology, diode pumped disk lasers, laser systems, and LK heat sink. It offers optics and optical systems, including objective lenses for laser material processing, customized and standardized objective lenses, optical coatings and measuring systems, and precision optical components; optical shaft measuring systems, optical 3D measurement technology, optical in-line inspection, vision-systems, and ultra-fast opto-electronic probe card; and optoelectronics and optoelectronic systems comprising system partner for optoelectronic systems, customized-specific optoelectronic systems, optoelectronics assemblies and subsystems, light modulation, and photodiodes and LEDs. In addition, the company offers road safety solutions, such as speed enforcement, average speed cameras, red light cameras, evaluation software, and traffic services; and civil security solutions, including automatic number plate recognition and data analysis software, border security, combating organized crime, protecting public places, and monitoring suspect vehicles. It serves automotive, defense and security, electronics and information technology, medical and life science, industry and mechanical engineering, semiconductor equipment, and public safety sectors. Jenoptik AG was founded in 1846 and is headquartered in Jena, Germany.
Full JNPKF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.